Cargando…

Androgen Receptors Act as a Tumor Suppressor Gene to Suppress Hepatocellular Carcinoma Cells Progression via miR-122-5p/RABL6 Signaling

Hepatocellular carcinoma (HCC) is a malignant tumor with a high degree of malignancy and a poor prognosis. Androgen receptor (AR) has been reported to play important roles in the regulation of the progression of HCC, but the underlying mechanisms of how AR regulates HCC initiation, progression, meta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Neng, Dou, Xiaolin, You, Xing, Li, Yixiong, Li, Xi, Liu, Guodong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564478/ https://www.ncbi.nlm.nih.gov/pubmed/34745992 http://dx.doi.org/10.3389/fonc.2021.756779

Ejemplares similares

Csi1 illuminates the mechanism and function of Rabl configuration
por: Hou, Haitong, et al.
Publicado: (2013)

The Rabl configuration limits topological entanglement of chromosomes in budding yeast
por: Pouokam, Maxime, et al.
Publicado: (2019)

LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation
por: Cheng, Di, et al.
Publicado: (2018)

Androgen-induced miR-135a acts as a tumor suppressor through downregulating RBAK and MMP11, and mediates resistance to androgen deprivation therapy
por: Wan, Xuechao, et al.
Publicado: (2016)

miR-122-mediated translational repression of PEG10 and its suppression in human hepatocellular carcinoma
por: Shyu, Yu-Chiau, et al.
Publicado: (2016)

The IFT81‐IFT74 complex acts as an unconventional RabL2 GTPase‐activating protein during intraflagellar transport
por: Boegholm, Niels, et al.
Publicado: (2023)

Nuclear genome organization in fungi: from gene folding to Rabl chromosomes
por: Torres, David E, et al.
Publicado: (2023)

miR-122 and hepatocellular carcinoma: from molecular biology to therapeutics
por: Fu, Xiao, et al.
Publicado: (2018)

Chronic inflammation contributes to the development of hepatocellular carcinoma by decreasing miR-122 levels
por: Li, Changfei, et al.
Publicado: (2016)

Combination therapies for MPNSTs targeting RABL6A-RB1 signaling
por: Kohlmeyer, Jordan L., et al.
Publicado: (2021)

RABL6A Promotes Pancreatic Neuroendocrine Tumor Angiogenesis and Progression In Vivo
por: Maharjan, Chandra K., et al.
Publicado: (2021)

P194 Disseminated fusariosis in h ematological malignancies with favo rable outcomes
por: Fernandez, Norma B., et al.
Publicado: (2022)

The Rabl chromosome configuration masks a kinetochore reassembly mechanism in yeast mitosis
por: Jiménez-Martín, Alberto, et al.
Publicado: (2022)

Early diagnostic evaluation of miR-122 and miR-224 as biomarkers for hepatocellular carcinoma
por: Amr, Khalda S., et al.
Publicado: (2017)

miR-122 Regulates Tumorigenesis in Hepatocellular Carcinoma by Targeting AKT3
por: Nassirpour, Rounak, et al.
Publicado: (2013)

Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine
por: Kishikawa, Takahiro, et al.
Publicado: (2015)

RABL6A Regulates Schwann Cell Senescence in an RB1-Dependent Manner
por: Kohlmeyer, Jordan L., et al.
Publicado: (2021)

Oncogenic RABL6A promotes NF1-associated MPNST progression in vivo
por: Kohlmeyer, Jordan L, et al.
Publicado: (2022)

RNA-binding protein AUF1 suppresses miR-122 biogenesis by down-regulating Dicer1 in hepatocellular carcinoma
por: Wu, Xia, et al.
Publicado: (2018)

Pan-cancer analysis of the oncogenic role of discs large homolog associated protein 5 (DLGAP5) in human tumors
por: Tang, Neng, et al.
Publicado: (2021)

Comparisons of Outcomes Between Adolescent and Young Adult with Older Patients After Radical Resection of Pancreatic Ductal Adenocarcinoma by Propensity Score Matching: A Single-Center Study
por: Tang, Neng, et al.
Publicado: (2021)

Efficient Suppression of Hepatitis C Virus Replication by Combination Treatment with miR-122 Antagonism and Direct-acting Antivirals in Cell Culture Systems
por: Liu, Fanwei, et al.
Publicado: (2016)

Retraction: miR-122 Regulates Tumorigenesis in Hepatocellular Carcinoma by Targeting AKT3
Publicado: (2017)

LncRNA RPPH1 acts as a molecular sponge for miR-122 to regulate Wnt1/β-catenin signaling in hepatocellular carcinoma
por: Zhou, Jian, et al.
Publicado: (2023)

RABL2 interacts with the intraflagellar transport-B complex and CEP19 and participates in ciliary assembly
por: Nishijima, Yuya, et al.
Publicado: (2017)

SNHG15 aids SARS-CoV-2 entry via RABL2A
por: Pushparaj, Samuel, et al.
Publicado: (2023)

Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitors
por: Israelow, Benjamin, et al.
Publicado: (2014)

MicroRNA-122 acts as tumor suppressor by targeting TRIM29 and blocking the activity of PI3K/AKT signaling in nasopharyngeal carcinoma in vitro
por: Yang, Yan, et al.
Publicado: (2018)

MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor Metabolism
por: Pan, Chenwei, et al.
Publicado: (2016)

miR-145-5p Acts as a Novel Tumor Suppressor in Hepatocellular Carcinoma Through Targeting RAB18
por: Wang, Baoying, et al.
Publicado: (2019)

miR-122 Targets Pyruvate Kinase M2 and Affects Metabolism of Hepatocellular Carcinoma
por: Liu, Angela M., et al.
Publicado: (2014)

Active glycolytic metabolism in CD133(+) hepatocellular cancer stem cells: regulation by MIR-122
por: Song, Kyoungsub, et al.
Publicado: (2015)

MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma
por: Turato, Cristian, et al.
Publicado: (2019)

Prognostic significance of miR-122 expression after curative resection in patients with hepatocellular carcinoma
por: Ha, Sang Yun, et al.
Publicado: (2019)

circCOL1A1 Promotes the Progression of Gastric Cancer Cells through Sponging miR-145 to Enhance RABL3 Expression
por: Ma, Yue, et al.
Publicado: (2021)

CEP19–RABL2–IFT-B axis controls BBSome-mediated ciliary GPCR export
por: Zhou, Zhuang, et al.
Publicado: (2022)

Potential relative quantities of miR-122 and miR-150 to differentiate hepatocellular carcinoma from liver cirrhosis
por: Gumilas, Nur Signa Aini, et al.
Publicado: (2022)

Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells
por: He, Jialin, et al.
Publicado: (2015)

HNF-4α inhibits hepatocellular carcinoma cell proliferation through mir-122-adam17 pathway
por: Yang, Guang, et al.
Publicado: (2020)

miR-3196 acts as a Tumor Suppressor and Predicts Survival Outcomes in Patients With Gastric Cancer
por: Chen, Guo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vehj5btfl206v5qva6vaafglpu